Disparities Details by Country of Birth for 2012
IID-7.3 : Children receiving 3+ doses of HepB vaccine by age 19–35 months (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Country of Birth for IID-7.3
IID-7.3 Maintain an effective vaccination coverage level of 3 doses of hepatitis B (hep B) vaccine among children by age 19 to 35 months
Children receiving 3+ doses of HepB vaccine by age 19–35 months (percent)
|Country of Birth||2012 1||Disparity|
|Outside US|| 84.3
1 Baseline has been revised. See Data Details for more information.
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 89.8%, was attained by persons who were born in the US.
- The worse group rate for this objective, 84.3%, was attained by persons who were born outside the US.
- The absolute difference (or range) between the best and worst group rates was 5.5 percentage points.
- The best group rate was <1.100 times the worst group rate.
Persons born in the US achieved the better group rate for this objective, 89.8%.
The better group rate was <1.1 times the rate among persons born outside the US.